SCHEMBL9530143

SCHEMBL9530143

CCCc1c(Cl)n(CC(C)C)c(=O)n1Cc1ccc(-c2ccccc2C(=O)O)cc1

nearest known ligand 0.57

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.53
AGTR1 P30556 2/20 0.52
AGTR2 P50052 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9554402 0.94 AGTR1 (0.58) AGTR1AGTR2
SCHEMBL9554040 0.92 BRS3 (0.48) AGTR1AGTR2
SCHEMBL9531021 0.91 PPARG (0.58) PPARGAGTR1AGTR2
SCHEMBL9554313 0.90 AGTR1 (0.53) PPARGAGTR1AGTR2
SCHEMBL9535160 0.90 PPARG (0.53) PPARG
SCHEMBL9536354 0.90 PPARG (0.53) PPARGAGTR1AGTR2
SCHEMBL9555008 0.90 PPARG (0.57) PPARGAGTR1AGTR2
SCHEMBL9554307 0.89 PPARG (0.52) PPARGAGTR1AGTR2
SCHEMBL9533921 0.89 AGTR1 (0.57) PPARGAGTR1AGTR2
SCHEMBL9530067 0.88 PPARG (0.52) PPARGAGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
EP-0555331-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS. SEARLE & CO (US) 1993-08-18 EP disclosed
WO-1992007834-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed